Proton pump inhibitors (PPIs) are a class of medications used to treat conditions involving excess stomach acid, such as gastroesophageal reflux disorder (GERD) and stomach ulcers. They work by ...

Proton pump inhibitors (PPIs) are a class of very effective and generally safe medicines used to treat heartburn, gastroesophageal reflux disease (GERD), and gastric ulcers.But not everyone who ...

Proton pump inhibitors (PPIs) are a type of medication that reduces how much acid your stomach produces. Doctors prescribe PPIs to treat stomach ulcers and symptoms of chronic acid reflux ...

Proton-pump inhibitors like pantoprazole are often used in people after surgical treatment for esophageal cancer. They reduce ...

Suggested treatments for eosinophilic esophagitis include PPIs, topical steroids, empiric food elimination diet, biologics, endoscopic dilation ...

Objective To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs). Design The United ...

Aims Proton pump inhibitors (PPIs) produce negative inotropic effects on the human myocardium at clinically relevant plasma concentrations. We conducted this study to determine whether PPI use was ...

Proton-pump inhibitors (PPIs) are the most effective medical therapy for patients with moderate-to-severe GERD and are widely prescribed to pregnant women. However, safety data about the use of ...

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

Can acid reflux medications cause migraines? New research links PPIs, H2 blockers, and antacids to a higher risk of headaches ...

Objectives This study aimed to assess whether the combined use of proton pump inhibitors (PPIs) with non-steroidal anti-inflammatory drugs (NSAIDs) or antibiotics (penicillins, macrolides, ...

This study aims to analyze the existence of information about deprescription in the leaflets of proton pump inhibitor (PPI) medications. The leaflets available on the Brazilian Health Regulatory ...